Industry Verticals »

All Categories

Insights »

About TMR »

OTC Consumer Health Products (Powder Form) Market

OTC Consumer Health Products (Powder Form) Market - (Indication- Skin Care, Nutritional Supplements, Oral Care, Wound Care Management, and Gastrointestinal; Distribution Channel - Hospital Pharmacy, Independent Pharmacies and Retail Stores, Hypermarkets and Supermarkets, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global OTC Consumer Health Products (Powder Form) Market: Snapshot

The global market for over-the-counter health products of powder form is projected to experience incremented demand at a CAGR of 3.6% during the forecast period of 2017 to 2025, which is primarily a reflection of growing awareness among the consumers regarding the prevalence of lifestyle diseases. In addition to that, escalating percentage of geriatric population, increasing disposable income, deep penetration of social media, and fitness trends are augmenting the demand in the global OTC consumer health products market. On the other hand, adverse effects of some of the supplements, the lack of valid literature, and counterfeit pharmaceuticals are hindering the market from attaining its true potential. The report estimates the global OTC consumer health products market to be worth US$40.6 bn by the end of the forecast period, which is 2025.

Nutritional Supplements Emerge as Leading Indication Segment

Based on indication, this TMR report segments the global OTC consumer health products market into skin care products, oral care products, nutritional supplements, gastrointestinal products, and wound care management products. In 2016, the nutritional supplements segment served the maximum demand, and is expected to remain most fruitful aspect of the market throughout the forecast period, which is primarily attributed to the growing demand for vitamins and dietary supplements and the sports nutrition products. The report observes that health conscience is increasing among the urban population as a result of changing lifestyle, growing percentage of geriatric population, increasing disposable income, and widespread penetration of social media. On the other hand, the gastrointestinal products segment is expected to sustain its position as second most important segment, as a result of increasing heartburns.

otc consumer health products market

North America to Sustain Position as Most Profitable Region

Out of five major regions evaluated by this report: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, the OTC consumer health products market earns maximum demand from North America, which houses two developed countries in the U.S. and Canada. In the near future, North America is expected to maintain its leading position, as a result of high adoption rate of OTC products, changing lifestyle choices, growing demand for healthier options, and escalating geriatric population. In addition to that, as a number of leading players have headquarters in the U.S., strategic acquisitions is expected to reshape the competitive landscape of OTC consumer health products market in North America.

Europe, currently, is the second most lucrative region, with Germany as the leading revenue generating country, although vastly populated region of Asia Pacific is projected to increment the demand for OTC consumer health products market at most robust CAGR during the forecast period of 2017 to 2025. In the near future, two of the most promising emerging economies, India and China, are expected to turn Asia Pacific into a goldmine for the vendors operating in the global OTC consumer health products market.

Some of the key companies currently operating in the global market for over-the-counter consumer health products of power form market are: Pfizer, Inc., Piramal Enterprises Ltd., Abbott Laboratories, Bayer AG, Sun Pharmaceuticals Ltd., GlaxosmithKline plc, Johnson & Johnson, Ipsen, Sanofi S.A., American Health, and Glenmark Pharmaceuticals Ltd. In the near future, development of new products that have fewer to no side effects, imparting awareness via social media and aggressive marketing, and geographical expansion is expected to be the common strategies by the key companies to expand their horizon and cope up with the intense competition.

The OTC Consumer Health Products (Powder Form) Market has been segmented as follows:

by Indication
  • Skin Care Products
  • Nutritional Supplements
  • Oral Care Products
  • Wound Care Management Products
  • Gastrointestinal Products
  • Others

by Distribution Channel
  • Hospital Pharmacy
  • Independent Pharmacies and Retail Stores
  • Hypermarkets and Supermarkets
  • Online Sales
  • Others

by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights 

    2. Assumptions and Research Methodology

    3. Executive Summary

    4. Market Overview
         4.1. Introduction
                4.1.1. Product Type Definition
                4.1.2. Industry Evolution / Developments 
         4.2. Overview
         4.3. Market Dynamics 
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunities
                4.3.4. Trends
         4.4. Global OTC Consumer Health Products (Powder Form) Analysis and Forecasts,2015–2025 
         4.5. Market Outlook
         4.6. Porter's Five Forces Analysis
         4.7. Value Chain Analysis
         4.8. Regulatory Scenario
         4.9. Factors influencing Rx to OTC Switch

    5. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Indication
         5.1. Introduction & Definition
         5.2. Key Findings / Developments
         5.3. Market Value Forecast By Indication, 2015–2025 
                5.3.1. Skin Care products 
                5.3.2. Nutritional Supplement Products
                5.3.3. Oral Care Products
                5.3.4. Wound Care Management Products
                5.3.5. Gastrointestinal Products
                5.3.6. Others
         5.4. Market Attractiveness, By Indication 

    6. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Distribution Channel  
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Market Value Forecast By Distribution Channel, 2015–2025
                6.3.1. Hospital Pharmacy
                6.3.2. Independent Pharmacies and Retail Stores
                6.3.3. Hypermarkets & Supermarkets
                6.3.4. Online Sales
                6.3.5. Others
         6.4. Market Attractiveness By Distribution Channel

    7. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Region 
         7.1. Introduction & Definition 
         7.2. Key Findings / Developments 
         7.3. Market Size (US$ Mn) Forecast, By Region 
                7.3.1. North America
                7.3.2. Europe
                7.3.3. Asia Pacific 
                7.3.4. Latin America
                7.3.5. Middle East & Africa
         7.4. Market Attractiveness By Region

    8. North America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
         8.1. Introduction
                8.1.1. Key Findings
         8.2. Market Value Forecast By Country, 2015-2025
                8.2.1. U.S.
                8.2.2. Canada
         8.3. Market Size (US$ Mn) Forecast, By Indication
                8.3.1. Skin Care products 
                8.3.2. Nutritional Supplement Products
                8.3.3. Oral Care Products
                8.3.4. Wound Care Management Products
                8.3.5. Gastrointestinal Products
                8.3.6. Others
         8.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
                8.4.1. Hospital Pharmacy
                8.4.2. Independent Pharmacies and Retail Stores
                8.4.3. Hypermarkets & Supermarkets
                8.4.4. Online Sales
                8.4.5. Others
         8.5. Market Attractiveness Analysis
                8.5.1. By Country
                8.5.2. By Indication
                8.5.3. By Distribution Channel

    9. Europe OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
         9.1. Introduction
                9.1.1. Key Findings
         9.2. Market Value Forecast By Country, 2015-2025
                9.2.1. U.K.
                9.2.2. Germany
                9.2.3. France
                9.2.4. Italy
                9.2.5. Spain
                9.2.6. Russia
                9.2.7. Rest of Europe
         9.3. Market Size (US$ Mn) Forecast, By Indication
                9.3.1. Skin Care products 
                9.3.2. Nutritional Supplement Products
                9.3.3. Oral Care Products
                9.3.4. Wound Care Management Products
                9.3.5. Gastrointestinal Products
                9.3.6. Others
                9.3.7. Market Size (US$ Mn) Forecast, By Distribution Channel 
                9.3.8. Hospital Pharmacy
                9.3.9. Independent Pharmacies and Retail Stores
                9.3.10. Hypermarkets & Supermarkets
                9.3.11. Online Sales
                9.3.12. Others
         9.4. Market Attractiveness Analysis
                9.4.1. By Country
                9.4.2. By Indication
                9.4.3. By Distribution Channel

    10. Asia Pacific OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
                10.1.2. Key Trends
         10.2. Market Value Forecast By Country, 2015-2025
                10.2.1. India
                10.2.2. China
                10.2.3. Japan
                10.2.4. Australia & New Zealand
                10.2.5. Rest of Asia Pacific 
         10.3. Market Size (US$ Mn) Forecast, By Indication
                10.3.1. Skin Care products 
                10.3.2. Nutritional Supplement Products
                10.3.3. Oral Care Products
                10.3.4. Wound Care Management Products
                10.3.5. Gastrointestinal Products
                10.3.6. Others
         10.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
                10.4.1. Hospital Pharmacy
                10.4.2. Independent Pharmacies and Retail Stores
                10.4.3. Hypermarkets & Supermarkets
                10.4.4. Online Sales
                10.4.5. Others
         10.5. Market Attractiveness Analysis
                10.5.1. By Country
                10.5.2. By Indication
                10.5.3. By Distribution Channel

    11. Latin America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
         11.1. Introduction
                11.1.1. Key Findings
         11.2. Market Value Forecast By Country, 2015-2025
                11.2.1. Brazil
                11.2.2. Mexico
                11.2.3. Rest of Latin America
         11.3. Market Size (US$ Mn) Forecast, By Indication
                11.3.1. Skin Care products 
                11.3.2. Nutritional Supplement Products
                11.3.3. Oral Care Products
                11.3.4. Wound Care Management Products
                11.3.5. Gastrointestinal Products
                11.3.6. Others
         11.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
                11.4.1. Hospital Pharmacy
                11.4.2. Independent Pharmacies and Retail Stores
                11.4.3. Hypermarkets & Supermarkets
                11.4.4. Online Sales
                11.4.5. Others
         11.5. Market Attractiveness Analysis
                11.5.1. By Country
                11.5.2. By Indication
                11.5.3. By Distribution Channel

    12. Middle East & Africa OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
         12.1. Introduction
                12.1.1. Key Findings
                12.1.2. Key Trends
         12.2. Market Value Forecast By Country, 2015-2025
                12.2.1. GCC Countries
                12.2.2. South Africa 
                12.2.3. Rest of Middle East & Africa
         12.3. Market Size (US$ Mn) Forecast, By Indication
                12.3.1. Skin Care products 
                12.3.2. Nutritional Supplement Products
                12.3.3. Oral Care Products
                12.3.4. Wound Care Management Products
                12.3.5. Gastrointestinal Products
                12.3.6. Others
         12.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
                12.4.1. Hospital Pharmacy
                12.4.2. Independent Pharmacies and Retail Stores
                12.4.3. Hypermarkets & Supermarkets
                12.4.4. Online Sales
                12.4.5. Others
         12.5. Market Attractiveness Analysis
                12.5.1. By Country
                12.5.2. By Indication
                12.5.3. By Distribution Channel

    13. Competition Landscape
         13.1. Market Player – Competition Matrix (By Tier and Size of companies)
         13.2. Market Share Analysis By Company (2016)
         13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
                13.3.1. Pfizer, Inc.
                          13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.1.2. Business Overview
                          13.3.1.3. Product Portfolio 
                          13.3.1.4. Financial Overview 
                          13.3.1.5. SWOT Analysis 
                          13.3.1.6. Strategic overview
                13.3.2. GlaxoSmithKline plc 
                          13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.2.2. Business Overview
                          13.3.2.3. Product Portfolio 
                          13.3.2.4. Financial Overview 
                          13.3.2.5. SWOT Analysis 
                          13.3.2.6. Strategic overview
                13.3.3. Johnson & Johnson 
                          13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.3.2. Business Overview
                          13.3.3.3. Product Portfolio 
                          13.3.3.4. Financial Overview 
                          13.3.3.5. SWOT Analysis 
                          13.3.3.6. Strategic overview
                13.3.4. Sun Pharmaceuticals Ltd. 
                          13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.4.2. Business Overview
                          13.3.4.3. Product Portfolio 
                          13.3.4.4. Financial Overview 
                          13.3.4.5. SWOT Analysis 
                          13.3.4.6. Strategic overview
                13.3.5. Piramal Enterprises Ltd.
                          13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.5.2. Business Overview
                          13.3.5.3. Product Portfolio 
                          13.3.5.4. Financial Overview 
                          13.3.5.5. SWOT Analysis 
                          13.3.5.6. Strategic overview
                13.3.6. Abbott Laboratories
                          13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.6.2. Business Overview
                          13.3.6.3. Product Portfolio 
                          13.3.6.4. Financial Overview 
                          13.3.6.5. SWOT Analysis 
                          13.3.6.6. Strategic overview
                13.3.7. Ipsen  
                          13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.7.2. Business Overview
                          13.3.7.3. Product Portfolio 
                          13.3.7.4. Financial Overview 
                          13.3.7.5. SWOT Analysis 
                          13.3.7.6. Strategic overview
                13.3.8. Bayer AG
                          13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.8.2. Business Overview
                          13.3.8.3. Product Portfolio 
                          13.3.8.4. Financial Overview 
                          13.3.8.5. SWOT Analysis 
                          13.3.8.6. Strategic overview
                13.3.9. Sanofi S.A 
                          13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.9.2. Business Overview
                          13.3.9.3. Product Portfolio 
                          13.3.9.4. Financial Overview 
                          13.3.9.5. SWOT Analysis 
                          13.3.9.6. Strategic overview
                13.3.10. Glenmark Pharmaceuticals Limited
                          13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.10.2. Business Overview
                          13.3.10.3. Product Portfolio 
                          13.3.10.4. Financial Overview 
                          13.3.10.5. SWOT Analysis 
                          13.3.10.6. Strategic overview
                13.3.11. American Health, Inc. 
                          13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                          13.3.11.2. Business Overview
                          13.3.11.3. Product Portfolio 
                          13.3.11.4. Financial Overview 
                          13.3.11.5. SWOT Analysis 
                          13.3.11.6. Strategic overview

    List of Tables

    Table 01: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
    Table 02: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 03: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Region, 2015–2025
    Table 04: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 05: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
    Table 06: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 07: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 08: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
    Table 09: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 10: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 11: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
    Table 12: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 13: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 14: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication,
    Table 15: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 16: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 17: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
    Table 18: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025

    List of Figures

    Figure 01: Global OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2017–2025
    Figure 02: Market Value Share By Indication (2017)
    Figure 03: Market Value Share By Distribution Channel (2017)
    Figure 04: Market Value Share By Region (2017)
    Figure 05: Porter's Five Force Analysis
    Figure 06: Value Chain Analysis
    Figure 07: Factors considered for successful Rx to OTC switch
    Figure 08: OTC Drug approval process – U.S.
    Figure 09: OTC Drug approval process in Japan
    Figure 10: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 11: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Skin Care, 2015–2025
    Figure 12: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nutritional Supplements, 2015–2025
    Figure 13: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Oral Care, 2015–2025
    Figure 14: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wound Care Management, 2015–2025
    Figure 15: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Gastrointestinal products, 2015–2025
    Figure 16: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Other products, 2015–2025
    Figure 17: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Indication
    Figure 18: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 19: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
    Figure 20: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Pharmacies & Retail Stores, 2015–2025
    Figure 21: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hypermarkets & Supermarkets, 2015–2025
    Figure 22: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2015–2025
    Figure 23: Global Others Market Revenue (US$ Mn), and Y-o-Y Growth (%), 2015–2025
    Figure 24: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Distribution Channel
    Figure 25: Global OTC Consumer Health Products (powder form) Market Revenue, US$ Mn, 2015–2025
    Figure 26: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Region, 2016 and 2025
    Figure 27: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Region
    Figure 28: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 29: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
    Figure 30: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
    Figure 31: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 32: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 33: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
    Figure 34: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
    Figure 35: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 36: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
    Figure 37: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
    Figure 38: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 39: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 40: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
    Figure 41: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
    Figure 42: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 43: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
    Figure 44: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
    Figure 45: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 46: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 47: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
    Figure 48: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
    Figure 49: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 50: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
    Figure 51: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
    Figure 52: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 53: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel,
    Figure 54: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
    Figure 55: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
    Figure 56: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 57: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
    Figure 58: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
    Figure 59: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 60: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 61: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
    Figure 62: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
    Figure 63: Global OTC Consumer Health Products (powder form) Market Share Analysis, by Company (2016)
    Figure 64: Pfizer, Inc., Breakdown of Net Sales (2016), by Region
    Figure 65: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
    Figure 66: GlaxoSmithKline plc, Breakdown of Net Sales, by Segment, 2016
    Figure 67: GlaxoSmithKline plc, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
    Figure 68: Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
    Figure 69: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
    Figure 70: Sun Pharmaceuticals Ltd., Breakdown of Net Sales, by Region, 2016
    Figure 71: Sun Pharmaceuticals Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
    Figure 72: Piramal Enterprises Ltd., Breakdown of Net Sales, by Business Segment, 2016
    Figure 73: Piramal Enterprises Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
    Figure 74: Abbott Laboratories, Breakdown of Net Sales (%Share), by Region (2016)
    Figure 75: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
    Figure 76: Ipsen, Breakdown of Net Sales, by Segment, 2016
    Figure 77: Ipsen, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
    Figure 78: Bayer AG, Breakdown of Net Sales (%), by Region (2016)
    Figure 79: Bayer AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2016
    Figure 80: Sanofi S.A, Breakdown of Net Sales, by Region, 2016
    Figure 81: Sanofi S.A, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
    Figure 82: Glenmark Pharmaceuticals Limited, Breakdown of Net Sales, by Region, 2016
    Figure 83: Glenmark Pharmaceuticals Limited, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016

Copyright © Transparency Market Research, Inc. All Rights reserved

OTC Consumer Health Products (Powder Form) Market

Schedule a Call